Thor Medical ASA (TRMEDNOK)

Currency in NOK
2.53
-0.02(-0.78%)
Closed·
TRMEDNOK is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.532.53
52 wk Range
1.414.82
Key Statistics
Prev. Close
2.53
Open
2.53
Day's Range
2.53-2.53
52 wk Range
1.41-4.82
Volume
5K
Average Volume (3m)
3.16K
1-Year Change
122.71%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TRMEDNOK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Thor Medical ASA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Thor Medical ASA Company Profile

As of July 3, 2023, Nordic Nanovector ASA was acquired by Thor Medical AS, in a reverse merger transaction. Nordic Nanovector ASA, a biopharmaceutical company, develops therapeutics for hematological cancers in Norway. The company’s lead product candidate is Betalutin, a CD37-targeting radioimmunotherapy for the treatment of patients with non-hodgkin lymphoma. Its preclinical development products include Humalutin for treatment of non-Hodgkin’s lymphoma; Alpha37, a CD37-targeting radioimmunotherapy for treating chronic lymphatic leukemia; and Multiple fully humanized anti-CD37 antibodies for treatment of haematological cancers and autoimmune diseases. The company is also developing 89Zr-NNV003, a CD37-targeting companion PET diagnostic for detection and dosimetry of CD37 expressing tumors. The company has collaboration agreements with Orano Med; Paul Scherrer Institute; ArevaMed; LegoChem Bio; and Heidelberg Pharma. It also has a research collaboration with the University of Pennsylvania development of a CD37-targeting CAR-T in haematological cancers. The company was formerly known as Nordic Nanovector AS and changed its name to Nordic Nanovector ASA in 2014. Nordic Nanovector ASA was incorporated in 2009 and is headquartered in Oslo, Norway.

Compare TRMEDNOK to Peers and Sector

Metrics to compare
TRMEDNOK
Peers
Sector
Relationship
P/E Ratio
0.0x0.0x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.0x2.6x
Price / LTM Sales
0.0x0.0x3.2x
Upside (Analyst Target)
0.0%0.0%40.5%
Fair Value Upside
Unlock0.0%4.4%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

TRMEDNOK Income Statement

FAQ

What Stock Exchange Does Thor Medical ASA Trade On?

Thor Medical ASA is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Thor Medical ASA?

The stock symbol for Thor Medical ASA is "TRMEDNOK."

What Is the Thor Medical ASA Market Cap?

As of today, Thor Medical ASA market cap is 862.00M.

What Is Thor Medical ASA's Earnings Per Share (TTM)?

The Thor Medical ASA EPS (TTM) is -0.03.

When Is the Next Thor Medical ASA Earnings Date?

Thor Medical ASA will release its next earnings report on 28 Aug 2025.

From a Technical Analysis Perspective, Is TRMEDNOK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Thor Medical ASA Stock Split?

Thor Medical ASA has split 0 times.

How Many Employees Does Thor Medical ASA Have?

Thor Medical ASA has 2 employees.

What is the current trading status of Thor Medical ASA (TRMEDNOK)?

As of 24 Jul 2025, Thor Medical ASA (TRMEDNOK) is trading at a price of 2.53, with a previous close of 2.53. The stock has fluctuated within a day range of 2.53 to 2.53, while its 52-week range spans from 1.41 to 4.82.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.